324 results
Featured

Injectable PrEP Drug Potentially Coming To Market

About 10 years ago, PrEP (or pre-exposure prophylaxis) was introduced to the world, making it easier for people to lower their risk of being infected with HIV.

Mark Riegel, MD

Search
Topics:
Syphilis Genital Herpes AIDS/HIV
Coronavirus Hinders Plan To Eradicate HIV In The U.S.

Coronavirus Hinders Plan To Eradicate HIV In The U.S.

The U.S. was on a roll to ending the HIV epidemic, but then the country was hit with the coronavirus. Now, the timeline to end HIV may not be as certain as it once was. That's because HIV and STI services have been stripped of its fundamental priorities.

Mark Riegel, MD

Are HIV-Positive People At Higher Risk For Flu Complications

Are HIV-Positive People At Higher Risk For Flu Complications

People who are HIV positive are at a higher risk of suffering from serious complications of the flu. This is especially true of individuals with a low CD4 cell count or are not on an antiretroviral therapy.

Mark Riegel, MD

Does An MS Drug Hold The Key For HIV Treatment

Does An MS Drug Hold The Key For HIV Treatment

U.S. and Canadian researchers feel that fingolimod offers a new type of therapy in the fight against HIV.

Mark Riegel, MD

Could HIV Transmission Rates Be Near Zero By 2030

Could HIV Transmission Rates Be Near Zero By 2030

According to a new report, there has been a 20 percent decline in the number of gay and bisexual men diagnosed with HIV. The report, which was based on 2019 numbers, shows 1,700 new HIV diagnoses in this demographic than the previous low in 2000, where there were 1,500 new cases.

Mark Riegel, MD

How The World Could Learn From AIDS Epidemic To Deal With COVID-19 Crisis

How The World Could Learn From AIDS Epidemic To Deal With COVID-19 Crisis

It’s been 40 years since the world health community came across a new disease that had no cure or treatment.

Mark Riegel, MD

Rukobia Shows Promise For Multi-Drug Resistant HIV Sufferers

Rukobia Shows Promise For Multi-Drug Resistant HIV Sufferers

The U.S. Food and Drug Administration recently approved the antiretroviral drug Rukobia for HIV-positive adults who have used other HIV drugs with little to no success for reasons like safety, intolerance or resistance.

Mark Riegel, MD

WHO Study Finds Countries In Danger Of Running Out of HIV Meds

WHO Study Finds Countries In Danger Of Running Out of HIV Meds

The World Health Organization carried out a study that found 73 countries are warning that they run the risk of running out of antiretroviral medications due to the COVID-19 pandemic. 24 countries are reported to have meager stocks of ARVs or troubles in securing supplies of these medications.

Mark Riegel, MD

Coping with HIV/AIDS: Your Next Few Steps to “Normalcy”

Coping with HIV/AIDS: Your Next Few Steps to “Normalcy”

Learning and finding out that you’ve been diagnosed with human immunodeficiency virus (HIV) is not an easy way to move forward to. It can be overwhelming to the very least and it’s hard to become optimistic for the future to come.

Mark Riegel, MD

What HIV Patients Need To Know About The Coronavirus

What HIV Patients Need To Know About The Coronavirus

The rise of the novel coronavirus cases around the world brought new hurdles for the medical community.

Mark Riegel, MD

Concerned about an STD?

Help stop the spread of STDs by knowing your status. Get tested today!

Compare My Testing Options